SOX2 and prostate carcinoma: Consequently, androgen deprivation therapy can induce YAP1 expression, which in turn regulates downstream factors such as SOX2 and Nanog to promote PCa stem/progenitor like cells and contribute to castration resistant prostate cancer growth (Figure 6H).